High-resolution melting molecular signatures for rapid identification of human papillomavirus genotypes

PLoS ONE

Volumn 7, Issue 8, 2012, Pages

  Lee, Ta Hsien ^a   Wu, Tzong Shoon ^a   Tseng, Ching Ping ^a,b   Qiu, Jiantai Timothy ^a,c  

^a University College of Medicine   (Taiwan)

^b CHANG GUNG UNIVERSITY   (Taiwan)

^c CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

GENOMIC DNA; VIRUS DNA;

ACCURACY; AMPLICON; ARTICLE; BIOINFORMATICS; CONTROLLED STUDY; DIAGNOSTIC KIT; FEMALE; GENETIC DATABASE; GENETIC VARIABILITY; GENOTYPE; HIGH RESOLUTION MELTING ANALYSIS; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPE 18; HUMAN PAPILLOMAVIRUS TYPE 39; HUMAN PAPILLOMAVIRUS TYPE 45; HUMAN PAPILLOMAVIRUS TYPE 52; HUMAN PAPILLOMAVIRUS TYPE 56; HUMAN PAPILLOMAVIRUS TYPE 58; HUMAN PAPILLOMAVIRUS TYPE 68; HUMAN TISSUE; NONHUMAN; NUCLEOTIDE SEQUENCE; REAL TIME POLYMERASE CHAIN REACTION; VALIDATION STUDY; WART VIRUS; ALPHAPAPILLOMAVIRUS; CLASSIFICATION; GENETICS; MOLECULAR GENETICS; SEQUENCE HOMOLOGY; VIRUS GENE;

ALPHAPAPILLOMAVIRUS; BASE SEQUENCE; GENES, VIRAL; GENOTYPE; MOLECULAR SEQUENCE DATA; REAL-TIME POLYMERASE CHAIN REACTION; SEQUENCE HOMOLOGY, NUCLEIC ACID;

EID: 84865185181     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0042051     Document Type: Article

References (49)

1. Schiffman MH, Bauer HM, Hoover RN, Glass AG, Cadell DM, et al. ((1993)) Epidemiologic evidence showing that human papillomavirus infection causes most cervical intraepithelial neoplasia. J Natl Cancer Inst 85:: 958--964.
2. Walboomers JM, Jacobs MV, Manos MM, Bosch FX, Kummer JA, et al. ((1999)) Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol 189:: 12--19.
3. zur Hausen H, ((1996)) Papillomavirus infections-a major cause of human cancers. Biochim Biophys Acta 1288:: F55--78.
4. Chua KL, Hjerpe A, ((1996)) Persistence of human papillomavirus (HPV) infections preceding cervical carcinoma. Cancer 77:: 121--127.
5. Hildesheim A, Schiffman MH, Gravitt PE, Glass AG, Greer CE, et al. ((1994)) Persistence of type-specific human papillomavirus infection among cytologically normal women. J Infect Dis 169:: 235--240.
6. Chao A, Lin CT, Hsueh S, Chou HH, Chang TC, et al. ((2004)) Usefulness of human papillomavirus testing in the follow-up of patients with high-grade cervical intraepithelial neoplasia after conization. Am J Obstet Gynecol 190:: 1046--1051.
7. Kulasingam SL, Hughes JP, Kiviat NB, Mao C, Weiss NS, et al. ((2002)) Evaluation of human papillomavirus testing in primary screening for cervical abnormalities: comparison of sensitivity, specificity, and frequency of referral. Jama 288:: 1749--1757.
8. Kulasingam SL, Pagliusi S, Myers E, ((2007)) Potential effects of decreased cervical cancer screening participation after HPV vaccination: an example from the U.S. Vaccine 25:: 8110--8113.
9. Lai CH, Huang HJ, Hsueh S, Chao A, Lin CT, et al. ((2007)) Human papillomavirus genotype in cervical cancer: a population-based study. Int J Cancer 120:: 1999--2006.
10. Lin P, Koutsky LA, Critchlow CW, Apple RJ, Hawes SE, et al. ((2001)) HLA class II DR-DQ and increased risk of cervical cancer among Senegalese women. Cancer Epidemiol Biomarkers Prev 10:: 1037--1045.
11. Manos MM, Kinney WK, Hurley LB, Sherman ME, Shieh-Ngai J, et al. ((1999)) Identifying women with cervical neoplasia: using human papillomavirus DNA testing for equivocal Papanicolaou results. Jama 281:: 1605--1610.
12. Raj GV, Moreno JG, Gomella LG, ((1998)) Utilization of polymerase chain reaction technology in the detection of solid tumors. Cancer 82:: 1419--1442.
13. Cuzick J, Clavel C, Petry KU, Meijer CJ, Hoyer H, et al. ((2006)) Overview of the European and North American studies on HPV testing in primary cervical cancer screening. Int J Cancer 119:: 1095--1101.
14. Franco EL, Ferenczy A, ((2006)) Is HPV testing with cytological triage a more logical approach in cervical cancer screening? Lancet Oncol 7:: 527--529.
15. Cope JU, Hildesheim A, Schiffman MH, Manos MM, Lorincz AT, et al. ((1997)) Comparison of the hybrid capture tube test and PCR for detection of human papillomavirus DNA in cervical specimens. J Clin Microbiol 35:: 2262--2265.
16. Iftner T, Germ L, Swoyer R, Kjaer SK, Breugelmans JG, et al. ((2009)) Study comparing human papillomavirus (HPV) real-time multiplex PCR and Hybrid Capture II INNO-LiPA v2 HPV genotyping PCR assays. J Clin Microbiol 47:: 2106--2113.
17. Low SH, Thong TW, Ho TH, Lee YS, Morita T, et al. ((1990)) Prevalence of human papillomavirus types 16 and 18 in cervical carcinomas: a study by dot and Southern blot hybridization and the polymerase chain reaction. Jpn J Cancer Res 81:: 1118--1123.
18. Baay MF, Quint WG, Koudstaal J, Hollema H, Duk JM, et al. ((1996)) Comprehensive study of several general and type-specific primer pairs for detection of human papillomavirus DNA by PCR in paraffin-embedded cervical carcinomas. J Clin Microbiol 34:: 745--747.
19. Jacobs MV, Snijders PJ, Voorhorst FJ, Dillner J, Forslund O, et al. ((1999)) Reliable high risk HPV DNA testing by polymerase chain reaction: an intermethod and intramethod comparison. J Clin Pathol 52:: 498--503.
20. de Roda Husman AM, Snijders PJ, Stel HV, van den Brule AJ, Meijer CJ, et al. ((1995)) Processing of long-stored archival cervical smears for human papillomavirus detection by the polymerase chain reaction. Br J Cancer 72:: 412--417.
21. Depuydt CE, Boulet GA, Horvath CA, Benoy IH, Vereecken AJ, et al. ((2007)) Comparison of MY09/11 consensus PCR and type-specific PCRs in the detection of oncogenic HPV types. J Cell Mol Med 11:: 881--891.
22. Dames S, Margraf RL, Pattison DC, Wittwer CT, Voelkerding KV, ((2007)) Characterization of aberrant melting peaks in unlabeled probe assays. J Mol Diagn 9:: 290--296.
23. Dames S, Pattison DC, Bromley LK, Wittwer CT, Voelkerding KV, ((2007)) Unlabeled probes for the detection and typing of herpes simplex virus. Clin Chem 53:: 1847--1854.
24. Gundry CN, Vandersteen JG, Reed GH, Pryor RJ, Chen J, et al. ((2003)) Amplicon melting analysis with labeled primers: a closed-tube method for differentiating homozygotes and heterozygotes. Clin Chem 49:: 396--406.
25. Herrmann MG, Durtschi JD, Bromley LK, Wittwer CT, Voelkerding KV, ((2006)) Amplicon DNA melting analysis for mutation scanning and genotyping: cross-platform comparison of instruments and dyes. Clin Chem 52:: 494--503.
26. Herrmann MG, Durtschi JD, Wittwer CT, Voelkerding KV, ((2007)) Expanded instrument comparison of amplicon DNA melting analysis for mutation scanning and genotyping. Clin Chem 53:: 1544--1548.
27. Seipp MT, Durtschi JD, Liew MA, Williams J, Damjanovich K, et al. ((2007)) Unlabeled oligonucleotides as internal temperature controls for genotyping by amplicon melting. J Mol Diagn 9:: 284--289.
28. Wittwer CT, Reed GH, Gundry CN, Vandersteen JG, Pryor RJ, ((2003)) High-resolution genotyping by amplicon melting analysis using LCGreen. Clin Chem 49:: 853--860.
29. Zhou L, Myers AN, Vandersteen JG, Wang L, Wittwer CT, ((2004)) Closed-tube genotyping with unlabeled oligonucleotide probes and a saturating DNA dye. Clin Chem 50:: 1328--1335.
30. Cheng JC, Huang CL, Lin CC, Chen CC, Chang YC, et al. ((2006)) Rapid detection and identification of clinically important bacteria by high-resolution melting analysis after broad-range ribosomal RNA real-time PCR. Clin Chem 52:: 1997--2004.
31. Lin JH, Tseng CP, Chen YJ, Lin CY, Chang SS, et al. ((2008)) Rapid differentiation of influenza A virus subtypes and genetic screening for virus variants by high-resolution melting analysis. J Clin Microbiol 46:: 1090--1097.
32. Stephens AJ, Inman-Bamber J, Giffard PM, Huygens F, ((2008)) High-resolution melting analysis of the spa repeat region of Staphylococcus aureus. Clin Chem 54:: 432--436.
33. Tajiri-Utagawa E, Hara M, Takahashi K, Watanabe M, Wakita T, ((2009)) Development of a rapid high-throughput method for high-resolution melting analysis for routine detection and genotyping of noroviruses. J Clin Microbiol 47:: 435--440.
34. Won H, Rothman R, Ramachandran P, Hsieh YH, Kecojevic A, et al. ((2010)) Rapid identification of bacterial pathogens in positive blood culture bottles by use of a broad-based PCR assay coupled with high-resolution melt analysis. J Clin Microbiol 48:: 3410--3413.
35. Chang SS, Hsu HL, Cheng JC, Tseng CP, ((2011)) An efficient strategy for broad-range detection of low abundance bacteria without DNA decontamination of PCR reagents. PLoS One 6:: e20303.
36. Yang S, Ramachandran P, Rothman R, Hsieh YH, Hardick A, et al. ((2009)) Rapid identification of biothreat and other clinically relevant bacterial species by use of universal PCR coupled with high-resolution melting analysis. J Clin Microbiol 47:: 2252--2255.
37. Huang HJ, Huang SL, Lin CY, Lin RW, Chao FY, et al. ((2004)) Human papillomavirus genotyping by a polymerase chain reaction-based genechip method in cervical carcinoma treated with neoadjuvant chemotherapy plus radical surgery. Int J Gynecol Cancer 14:: 639--649.
38. Munoz N, Bosch FX, de Sanjose S, Herrero R, Castellsague X, et al. ((2003)) Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med 348:: 518--527.
39. Kwok S, Kellogg DE, McKinney N, Spasic D, Goda L, et al. ((1990)) Effects of primer-template mismatches on the polymerase chain reaction: human immunodeficiency virus type 1 model studies. Nucleic Acids Res 18:: 999--1005.
40. Huang MM, Arnheim N, Goodman MF, ((1992)) Extension of base mispairs by Taq DNA polymerase: implications for single nucleotide discrimination in PCR. Nucleic Acids Res 20:: 4567--4573.
41. Gravitt PE, Peyton CL, Apple RJ, Wheeler CM, ((1998)) Genotyping of 27 human papillomavirus types by using L1 consensus PCR products by a single-hybridization, reverse line blot detection method. J Clin Microbiol 36:: 3020--3027.
42. Sandri MT, Lentati P, Benini E, Dell'Orto P, Zorzino L, et al. ((2006)) Comparison of the Digene HC2 assay and the Roche AMPLICOR human papillomavirus (HPV) test for detection of high-risk HPV genotypes in cervical samples. J Clin Microbiol 44:: 2141--2146.
43. van Ham MA, Bakkers JM, Harbers GK, Quint WG, Massuger LF, et al. ((2005)) comparison of two commercial assays for detection of human papillomavirus (HPV) in cervical scrape specimens: validation of the Roche AMPLICOR HPV test as a means to screen for HPV genotypes associated with a higher risk of cervical disorders. J Clin Microbiol 43:: 2662--2667.
44. Tucker RA, Unger ER, Holloway BP, Swan DC, ((2001)) Real-time PCR-based fluorescent assay for quantitation of human papillomavirus types 6, 11, 16, and 18. Mol Diagn 6:: 39--47.
45. Schmitz M, Scheungraber C, Herrmann J, Teller K, Gajda M, et al. ((2009)) Quantitative multiplex PCR assay for the detection of the seven clinically most relevant high-risk HPV types. J Clin Virol 44:: 302--307.
46. Coutlee F, Ratnam S, Ramanakumar AV, Insinga RR, Bentley J,et al. Distribution of human papillomavirus genotypes in cervical intraepithelial neoplasia and invasive cervical cancer in Canada. J Med Virol 83:: 1034--1041.
47. Sjoeborg KD, Trope A, Lie AK, Jonassen CM, Steinbakk M, et al. ((2010)) HPV genotype distribution according to severity of cervical neoplasia. Gynecol Oncol 118:: 29--34.
48. Trottier H, Mahmud S, Costa MC, Sobrinho JP, Duarte-Franco E, et al. ((2006)) Human papillomavirus infections with multiple types and risk of cervical neoplasia. Cancer Epidemiol Biomarkers Prev 15:: 1274--1280.
49. Mori S, Nakao S, Kukimoto I, Kusumoto-Matsuo R, Kondo K, et al. ((2011)) Biased amplification of human papillomavirus DNA in specimens containing multiple human papillomavirus types by PCR with consensus primers. Cancer Sci 102:: 1223--1227.